KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $89,415,000 | -8.6% | 1,994,083 | +13.9% | 0.02% | -20.0% |
| Q3 2016 | $97,823,000 | +18.1% | 1,751,216 | +5.7% | 0.02% | +11.1% |
| Q2 2016 | $82,840,000 | +19.6% | 1,656,795 | +9.9% | 0.02% | +12.5% |
| Q1 2016 | $69,242,000 | -14.6% | 1,508,215 | +14.6% | 0.02% | -15.8% |
| Q4 2015 | $81,074,000 | +8.0% | 1,315,703 | -2.4% | 0.02% | 0.0% |
| Q3 2015 | $75,081,000 | -1.3% | 1,348,437 | +8.1% | 0.02% | +5.6% |
| Q2 2015 | $76,038,000 | +83.0% | 1,247,132 | +73.1% | 0.02% | +80.0% |
| Q1 2015 | $41,562,000 | +4.9% | 720,562 | +4.9% | 0.01% | 0.0% |
| Q4 2014 | $39,623,000 | +625.2% | 687,063 | +258.4% | 0.01% | +400.0% |
| Q3 2014 | $5,464,000 | – | 191,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |